Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Oral EBP05 in Postmenopausal Women with Low Bone Mass
NCT04003467Phase 2Completed
- Sponsor
- Entera Bio Ltd.
- Start
- Jun 2019
- Primary completion
- Apr 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of EB613 in osteoporosis, sponsored by Entera Bio Ltd.. Started Jun 2019; status: completed.
02
Drugs
EB613
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04003467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003467.